Characteristic | Number (%) |
---|---|
Sex | |
Male | 28(64%) |
Female | 16(36%) |
Age (years) | |
Median | 64.5 |
Range | 39–83 |
Preoperative RT | 0 |
Neoadjuvant chemotherapy | 0 |
Postoperative RT | 0 |
Adjuvant chemotherapy | 19 |
Histology | |
Adenocarcinoma | 40 (91%) |
Mucinous adenocarcinoma | 3 (7%) |
Small intestinal neuroendocrine carcinoma | 1 (2%) |
Pathologic T stage | |
T3 | 44 (100%) |
Pathologic N stage | |
N0 | 27 |
N1 | 11 |
N2 | 6 |
Pathologic M stage | |
M0 | 44 |
M1 | 0 |
Number lymph nodes examined | |
Median | 19 |
Range | 7–33 |
Number lymph nodes positive | |
Mean | 2 |
Range | 0–15 |
Follow-up time (months) | |
Median | 20.5 |
Range | 6.1–38.8 |